# Effectiveness of a Biosimilar Epoetin Alfa in Stable 'End Stage Renal Failure'

> **NCT02341547** · — · UNKNOWN · sponsor: **Penang Hospital, Malaysia** · enrollment: 44 (estimated)

## Conditions studied

- End Stage Renal Failure
- Anaemia

## Interventions

- **DRUG:** a Biosimilar Epoetin Alfa

## Key facts

- **NCT ID:** NCT02341547
- **Lead sponsor:** Penang Hospital, Malaysia
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-02
- **Primary completion:** 2015-11
- **Final completion:** 2015-12
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2015-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02341547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02341547, "Effectiveness of a Biosimilar Epoetin Alfa in Stable 'End Stage Renal Failure'". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02341547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*